Special Commission on the Public Health Effects of Xylazine Final Report
Summary
Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl
Bill status
introduced
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 30, 2026
Last action Mar 30, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about SD 3797
Scope: MA
Hi! I can help you understand SD 3797. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline